Inhibition of Na-K-2Cl cotransport and bumetanide binding by ethacrynic acid, its analogues, and adducts.
The inhibitory effect of ethacrynic acid (EA) and a variety of its derivatives on Na-K-2Cl cotransport in avian erythrocytes was investigated. The most potent compound tested was the adduct of EA with L-cysteine, with an IC50 of 7.2 x 10(-7) M. EA itself, dihydro-EA, EA-D-cysteine, and adducts of EA with other sulfhydryl (-SH) compounds were much less potent. The mechanism of action of EA and EA-L-cysteine differed in several respects: 1) EA-L-cysteine acted more rapidly than EA (half times of < 1 and 4 min, respectively, at 37 degrees C); 2) the action of EA-L-cysteine was reversible by washing, whereas that of EA was not; and 3) the degree of inhibition by EA-L-cysteine varied with medium [K], whereas that of EA did not. The inhibitory effects of both EA-L-cysteine and EA were affected by medium [Na] and [Cl]. We conclude that EA-L-cysteine does not "deliver" EA to transport-related -SH residues or act as an alkylating agent but has some stereospecific effect on cotransport that is a property of the entire molecule. EA does appear to inhibit cotransport by alkylating -SH residues, as closely related compounds lacking the ability to covalently react with such groups were reversible, and other -SH reagents (e.g., N-ethylmaleimide) also inhibited cotransport. EA, EA-L-cysteine, and EA-D-cysteine all inhibited [3H]bumetanide binding to membranes from activated avian erythrocytes at concentrations similar to those that inhibited cotransport. It is possible that the EA and bumetanide types of diuretics interact with closely apposed sites on the Na-K-2Cl cotransporter.
Department of Pharmacological and Physiological Sciences, University of Chicago, Illinois 60637.
H C
HC
Palfrey
S
S
Leung
D000818:Animals; D002034:Bumetanide / Q000097:blood*; D002352:Carrier Proteins / Q000037:antagonists & inhibitors / Q000097:blood*; D002645:Chickens; D002712:Chlorides / Q000097:blood; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism*; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D004976:Ethacrynic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology*; D066298:In Vitro Techniques; D007700:Kinetics; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D028021:Sodium-Potassium-Chloride Symporters; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D014422:Turkeys
D002352:Carrier Proteins; D002712:Chlorides; D028021:Sodium-Potassium-Chloride Symporters; D013438:Sulfhydryl Compounds; D002034:Bumetanide; D012964:Sodium; D004976:Ethacrynic Acid; D011188:Potassium